We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA, Industry Talk Regulatory Science Pilot, Interchangeability Guidance at BsUFA Meeting
FDA, Industry Talk Regulatory Science Pilot, Interchangeability Guidance at BsUFA Meeting
The FDA’s latest biosimilar user fee negotiations with industry representatives focused on the agency’s proposals for a regulatory science pilot program and guidance on biosimilar interchangeability, as well as furthering discussions on several other topics.